Acute coronary syndrome (ACS) is a continuum with different forms of presentation, clinical contexts, electrocardiographic parameters and biomarkers. However, most of the diagnostic and intervention strategies are similar in all of them.
While invasive management is recommended in all ACS cases (with few exceptions), its timing varies according to the risk of the patient.
Antithrombotic therapy is a cornerstone to managing ACS. While there is a default strategy for all patients, some alternatives are available according to the bleeding and ischaemic risk of the patients during the year following the index event.
Long-term interventions are key to improving the long-term prognosis of patients with ACS. State-of-the-art management of ACS must include patients in decision making throughout the process.
The content below, selected by Ronen Beeri, Robert Byrne, Borja Ibanez, Margret Leosdottir, JJ Coughlan, and Maria Rubini Gimenez, will help you expand your knowledge of acute coronary syndromes.
ESC 2023 Clinical Practice Guidelines Webinars
What’s new in treating acute coronary syndrome: an overview
8 November 2023
With Robert Byrne, Borja Ibanez and Vijay Kunadian
Management of multivessel disease
15 November 2023
With Borja Ibanez, Colin Berry, and JJ Coughlan
Most recent changes on management of MINOCA
22 November 2023
With Vijay Kunadian, Mary Galbraith and Maria Rubini Gimenez
Antithrombotic strategy for ACS: from default to alternative strategies
28 November 2023
With Robert Byrne, Francisco Javier, and Pascal Vranckx
2023 ESC Guidelines for the management of acute coronary syndromes
2023 ESC Guidelines for the Management of Acute Coronary Syndromes
Acute phase management of patients with a working diagnosis of NSTE-ACS
Antithrombotic therapy in patients with ACS: default and alternative strategies
Special ACS situations, long-term treatment after ACS, and patient's perspective
2023 ESC Guidelines for the Management of Acute Coronary Syndromes - key messages
2023 ESC Guidelines for the Management of Acute Coronary Syndromes - panel discussion
A polypill strategy in secondary prevention: results of the SECURE trial
Management of ASCVD risk in patients with established ASCVD and on a population level.
Rapid diagnostic algorithms for non-ST-segment elevation myocardial infarction
STOPDAPT-3: An Aspirin-Free antithrombotic strategy for percutaneous coronary intervention
TOMAHAWK: immediate angiography after out-of-hospital cardiac arrest
Exclusive for members
ACVC Biomarker Talk Series - Rapid diagnostic algorithms for NSTEMI
Reducing risk in the post-MI patient
What the cardiologist must know: glucose-lowering medication after myocardial infarction in hospital and after discharge. Glucose-lowering medication after myocardial infarction:
Proposal for a standardised discharge letter after hospital stay for acute myocardial infarction
Is the contemporary care of the older persons with acute coronary syndrome evidence-based?